Our previous results in osteosarcoma cells corroborated the hypothesis that increase of PLCB1 expression might be opposite to cancer progression, confirming a differentiating role (Lo Vasco et al. 2013, 2014a, b, 2015). This evidence concerns the gene PLCB1 and cancer.